Vimarsana
Biggest News Aggregation in the World

Page 10 - Denisel Cote News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Denisel Cote. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Denisel Cote Today - Breaking & Trending Today

Judge Says Shkreli's Picasso Can Be Sold To Pay $2.6M Debt - Vimarsana News

Judge Says Shkreli's Picasso Can Be Sold To Pay $2.6M Debt

A New York federal judge on Thursday authorized a receiver to sell a Picasso etching seized from imprisoned "pharma bro" Martin Shkreli to settle a $2.6 million debt the former drug firm executive owes to a Pennsylvania pharmaceutical industry consultant.

Source: law360.com
BREAKING: 'Pharma Bro No More' To Pay $65M, Banned From Industry - Vimarsana News

BREAKING: 'Pharma Bro No More' To Pay $65M, Banned From Industry

A New York federal judge on Friday banned Martin Shkreli from participating in the pharmaceutical industry for life and fined him $64.6 million for increasing the price of a life-saving drug by 4,000% while blocking generic rivals.

Source: law360.com
Ex-Vyera CEO Criticizes Shkreli At Drug-Pricing Bench Trial - Vimarsana News

Ex-Vyera CEO Criticizes Shkreli At Drug-Pricing Bench Trial

Former Vyera Pharmaceuticals CEO Eliseo Salinas told a Manhattan federal judge Tuesday that he thinks Martin Shkreli's 2015 move to dramatically jack up the price of an anti-parasitic drug the company controlled was "crazy," "irresponsible" and "careless."

Source: law360.com
Ex-Vyera CEO Criticizes Shkreli At Drug-Pricing Bench Trial - Vimarsana News

Ex-Vyera CEO Criticizes Shkreli At Drug-Pricing Bench Trial

Former Vyera Pharmaceuticals CEO Eliseo Salinas told a Manhattan federal judge Tuesday that he thinks Martin Shkreli's 2015 move to dramatically jack up the price of an anti-parasitic drug the company controlled was "crazy," "irresponsible" and "careless."

Source: law360.com
Shkreli Won't Take The Stand At FTC Antitrust Trial - Vimarsana News

Shkreli Won't Take The Stand At FTC Antitrust Trial

Martin Shkreli has informed a Manhattan federal judge that he will not attend a December bench trial on the Federal Trade Commission's allegations that he and his company, Vyera Pharmaceuticals, monopolized the market for a lifesaving parasitic drug.

Source: law360.com